Skip to content
Catalyst

knowcompoundscrocin-1

Specimen compound organic compound

Crocin-1

A diester that is crocetin in which both of the carboxy groups have been converted to their gentiobiosyl esters.

Continue

It is one of the water-soluble yellow-red pigments of saffron and is used as a spice for flavouring and colouring food. Note that in India, the term 'Crocin' is also used by GlaxoSmithKline as a brand-name for paracetamol.”

fig. 1Crocin-1 · findings by direction and evidence strength
Formula
C44H64O24
Molar mass
976.972 g/mol
InChIKey
SEBIKDIMAPSUBY-RTJKDTQDSA-N

↑ raised 1 finding in 1 endpoint · ↓ lowered 9 in 8 · – no difference found 4 in 4

01 · the evidence, ordered

What the evidence says

Strong
0
Moderate
3
Limited
0
Very limited
11
Insufficient
0

How to read these marks

Fig. 2 Crocin-1 CHEBI:79068 12 endpoints 14 findings
×1.60
Labels
CompoundInspector

Crocin-1

Most findings

  • C-reactive protein concentration×2
  • Triglycerides×2
  • Beck Depression Inventory (BDI) total score×1
  • Pittsburgh Sleep Quality Index global score×1
Show the remaining 8Show the first 4
  • Fasting blood glucose×1
  • HDL cholesterol×1
  • Interleukin-6 concentration×1
  • LDL cholesterol×1
  • Malondialdehyde (circulating)×1
  • Total antioxidant capacity×1
  • Total cholesterol (TC)×1
  • Tumour necrosis factor alpha concentration×1

36 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

  1. Triglyceridescontested
  2. Beck Depression Inventory (BDI) total score
  3. Pittsburgh Sleep Quality Index global score
  4. C-reactive protein concentration
  5. Fasting blood glucose
  6. HDL cholesterol
  7. Interleukin-6 concentration
  8. LDL cholesterol
  9. Malondialdehyde (circulating)
  10. Total antioxidant capacity
  11. Total cholesterol (TC)
  12. Tumour necrosis factor alpha concentration
Show the remaining 4Show the first 8
fig. 3 · 12 endpoints · 14 findingscontested · an endpoint whose findings disagree

02 · contested · 1 endpoint

Where the findings disagree

  1. 012 findings

    Triglycerides

    ↓ lowered
    1
    – no difference found
    1

03 · findings

What crocin-1 moved, and by how much

  • MD mean difference · SMD standardised mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
Direction
Strength, at least

12 of 14 shown

  1. Pittsburgh Sleep Quality Index global scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
    Who
    Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
    Dose studied
    30 mg/day crocin (15 mg twice daily)

    After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”

    Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink
  2. TriglyceridescontestedMoved: lowersEvidence: ModeratePaper: PMID 362090912022
    Who
    Adults with type 2 diabetes and microalbuminuria on routine antidiabetic, antihypertensive and lipid-lowering care; crocin 15 mg/day versus placebo
    Dose studied
    15 mg crocin tablet daily

    As listed in Table 2, comparison of the crocin and placebo groups for changes in variables (before- after) showed that mean serum TG levels decreased significantly in the crocin group compared with the increasing values in the placebo group (P-Value = 0.03).”

    Quoted verbatim from Evaluation of therapeutic effects of crocin in attenuating the progression of diabetic nephropathy: a preliminary randomized triple-blind placebo-controlled trial.RCT · 3 monthsPermalink
  3. Beck Depression Inventory (BDI) total scoreMoved: lowersEvidence: ModeratePaper: PMID 307957852019
    Who
    Patients under methadone maintenance treatment (methadone in both arms); crocin 30 mg/day versus placebo
    Dose studied
    30 mg/day crocin (15 mg twice daily)

    After 8-week intervention, crocin significantly decreased Beck Depression Inventory (b - 6.66; 95% CI, - 9.88, - 3.45; P < 0.0001), Beck Anxiety Inventory (b - 4.35; 95% CI, - 5.94, - 2.75; P < 0.0001), general health questionnaire (b - 4.45; 95% CI, - 7.68, - 1.22; P = 0.008) and Pittsburgh Sleep Quality Index (b - 2.73; 95% CI, - 3.74, - 1.73; P < 0.0001) in patients under MMT, compared with the placebo.”

    Quoted verbatim from The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial.RCT · 8 weeksPermalink
  4. Fasting blood glucoseMoved: lowersEffect, as reportedMD−6.52[−11.96 to −1.08]Evidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  5. Total cholesterol (TC)Moved: lowersEffect, as reportedMD−4.64[−8.19 to −1.09]Evidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Results of the pooled random-effect size analysis showed just a significant decreasing effect of crocin supplementation on FBG (WMD: -6.52 mg/l, 95 % CI, -11.96, -1.08; p = 0.019) and TC (WMD: -4.64 mg/l, 95 % CI, -8.19, -1.09; p = 0.010).”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  6. LDL cholesterolMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  7. TriglyceridescontestedMoved: no difference foundEvidence: Very limitedPaper: PMID 329517482020
    Who
    Participants in eight clinical trials of crocin supplementation (nine effect sizes), pooled
    Dose studied
    not reported

    Crocin supplements did not have any significant effect on serum TG (p = 0.144) levels, LDL-C (p = 0.161), and HDL-C (p = 0.872) levels.”

    Quoted verbatim from The effect of crocin supplementation on lipid concentrations and fasting blood glucose: A systematic review and meta-analysis and meta-regression of randomized controlled trials.meta-analysisPermalink
  8. C-reactive protein concentrationMoved: lowersEvidence: Very limitedreplicated ×1Paper: PMID 383068882024
    Who
    Patients with multiple sclerosis; crocin 15 mg twice daily (30 mg/day) versus placebo
    Dose studied
    15 mg crocin tablet twice daily (30 mg/day)

    The data analysis using ANCOVA showed that supplementation with crocin for 8 weeks significantly lowered hs-CRP levels (p-value= 0.01).”

    Quoted verbatim from Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.RCT · 8 weeksPermalink
  9. C-reactive protein concentrationMoved: lowersEffect, as reportedSMD−0.5[−0.86 to −0.13]Evidence: Very limitedreplicated ×1Paper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  10. Tumour necrosis factor alpha concentrationMoved: lowersEffect, as reportedSMD−1.96[−2.72 to −1.19]Evidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  11. Total antioxidant capacityMoved: raisesEffect, as reportedSMD1.48[0.52 to 2.43]Evidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Also, crocin supplementation led to a significant increase in total antioxidant capacity (TAC) (SMD: 1.48; 95%CI: 0.52 to 2.43; p = 0.002).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink
  12. Interleukin-6 concentrationMoved: lowersEffect, as reportedSMD−3.52[−6.84 to −0.2]Evidence: Very limitedPaper: PMID 396326022025
    Who
    Adults supplemented with crocin in pooled randomised clinical trials
    Dose studied
    not reported

    Our findings indicated that crocin supplementation significantly reduced c-reactive protein (CRP) levels (SMD: -0.50; 95%CI: -0.86 to -0.13; p = 0.008), tumor necrosis factor-α (TNF-α) (SMD: -1.96; 95%CI: -2.72 to -1.19; p < 0.001), and interleukin-6 (IL-6) (SMD: -3.52; 95%CI: -6.84 to -0.20; p = 0.03).”

    Quoted verbatim from Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta-Analysis.meta-analysisPermalink

No dose is advised.

  • MD mean difference · SMD standardised mean difference. Brackets: the interval as reported.
  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

04 · identity

Structure

fig. 4Crocin-1 · 2D structure · ChEBI’s SMILES
Charge
0
3D model
None at PubChem
SMILES
CC(/C=C/C=C(C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=CC=CC=C(C)C=CC=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O

05 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reactions · Rhea
1reaction

06 · on the label · 274 products

Labelled products

Source: NIH DSLD · Ingredient: crocin-1 · 274 products · Declared amount per serving: 1.5–1,156 mg

212 labels state an amount62 do not

  • Ab Cuts Sleek & LeanThermo Rise 02100 mgper 2 softgelsDSLD:23446
  • AceworkzSaffron Extract88.5 mgper 1 veggie capsuleDSLD:258789
  • AddrenaNo-Stim352 mgper 2 tabletsDSLD:206848
  • Advanced Nutrition by ZahlerChildCalm Fruit Punch FlavorSaffron Stigma Extract28 mgper 2 tabletsDSLD:260021
  • Advanced Nutrition by ZahlerChildCalm Fruit Punch FlavorSaffron Stigma Extract28 mgper 1 tabletDSLD:313722
  • Advanced Nutrition by ZahlerMasterMindSaffron Stigma Extract28 mgper 1 capsuleDSLD:316633
  • Advanced Nutrition by ZahlerTeen FocusSaffron Extract28 mgper 1 capsuleDSLD:301148
  • Allergy Research GroupMood Support15 mgper 1 capsuleDSLD:233304
  • AmbrosiaRitual-PMSaffron Stigma Extract28 mgper 2 capsulesDSLD:334103
  • AOR Advanced Orthomolecular Research AdvancedSaffron30 mgper 1 capsuleDSLD:214874
  • Approved ScienceSaffron +BioperineCrocins · Standardized to 3% Crocin, 2% Safranal30 mgper 2 capsulesDSLD:313341
  • ArbonneFeelFit Watermelon Kiwi FlavorCrocus sativus Flower Extract, Powder6 mgper 3.43 gDSLD:335883
Show the remaining 262Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

07 · the record

Sources

47

papers screened for crocin-1

admitted
5
read and discarded
7
not read yet
35

The screening record, every paper and why

Sources cited

5 papers · 14 findings

Show every paper citedHide the papers cited

Other names · 20

alpha-crocin · bis-(beta-D-gentiobiosyl) crocetin · C.I. 75100 · Crocetin A · crocetin di-β-D-gentiobiose ester · crocetin di-gentiobiose ester · crocetin digentiobioside · Crocin · Crocin 1 · Crocin A · crocine · Digentiobiosyl-8,8'-diapocarotene-8,8'-dioate · Digentiobiosyl-Crocetin · Gardenia Yellow · Natural red 1 · Natural yellow 19 · Natural yellow 6 · Saffron · trans-crocetin bis(β-D-gentiobiosyl) ester

systematic · bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate